Allakos Announces Positive Results From Its Ongoing Phase 1 Trial of Ak006 in Healthy Volunteers, With Ak006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
Allakos宣佈，其正在進行的Ak006健康志願者I期試驗取得了積極結果，Ak006在肥大細胞上表現出高受體佔有率，並具有良好的安全性。